As of 2025-07-07, the Fair Value of Phathom Pharmaceuticals Inc (PHAT) is -24.77 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 8.92 USD, the upside of Phathom Pharmaceuticals Inc is -377.65%.
With the market price of 8.92 USD and our fair value calculation, Phathom Pharmaceuticals Inc (PHAT) is not a good investment. Investing in PHAT stocks now will result in a potential loss of 377.65%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -129.07 | -143.88 | -197.72 | -201.59 | -334.33 | -201.32 |
| YoY growth | 49.41% | -11.47% | -37.42% | -1.96% | -65.84% | -13.46% |
| Market Cap (mil) | 622.71 |
| P/E | |
| Forward P/E |
| EPS | -4.95 |
| Avg earnings growth rate | -13.46% |
| TTM earnings | -345.79 |